12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xilonix regulatory update

FDA granted Fast Track designation for XBiotech's Xilonix to treat cachexia. By year end,...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >